HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY - Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 3.570-3.740 for the period, compared to the consensus EPS estimate of 3.760. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Raymond James lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Tuesday, February 25th. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research report on Tuesday, December 10th. Barrington Research reaffirmed an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, March 14th. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. Finally, Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $112.92.

Remove Ads

HealthEquity Stock Up 0.3 %

HQY stock traded up $0.28 during midday trading on Friday, hitting $84.88. The company's stock had a trading volume of 1,740,588 shares, compared to its average volume of 693,710. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $7.36 billion, a PE ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The firm's 50-day moving average is $104.90 and its 200-day moving average is $95.55.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.20% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.